Latest Publications

Share:

Beyond the Valuation Gap - Flexing Earnouts in the Current M&A Environment

Increased use of earnouts is likely to facilitate M&A deals across sectors in Europe. Earnouts are increasingly common in European M&A. The growing prevalence of this contractual provision — in which additional...more

Corporate Reorganisations - 2023 - United Kingdom - England & Wales

What types of transactions are classifed as ‘corporate reorganisations’ in your jurisdiction? The term ‘corporate reorganisation’ can be used to mean a wide variety of transactions, but is most typically used to refer to...more

European Healthcare & Life Sciences Market Update - H1 2022

Welcome to the first edition of our European Healthcare & Life Sciences Market Update, a new report summarising key emerging trends, opportunities, and challenges facing the market in 2022. During the last 12 months, the...more

FCA Consults on Rule Changes to Accommodate SPACs

Proposed changes to the UK Listing Rules would allow certain SPACs to avoid a listing suspension. Key Points: ..The FCA is proposing to amend its rules so that SPACs meeting certain conditions and disclosure...more

Corporate Reorganisations - 2021

What types of transactions are classified as ‘corporate reorganisations’ in your jurisdiction? The term ‘corporate reorganisation’ can be used to mean a wide variety of transactions, but is most typically used to refer to...more

IFLR M&A Report 2021

If 2020 was the year that COVID-19 precipitated extraordinary government intervention and regulation of our lives, 2021 looks set to be the year that regulatory interventions in M&A precipitate changes to the way that...more

Healthcare Tech: How Are Licensing Agreements Bridging the Industry Divide? [Video]

As the healthcare and technology sectors converge to create revolutionary new products and innovations, companies operating in very distinct regulatory and business environments must find ways to adapt and cooperate. When...more

PE Views: Insights on the World of Private Equity - December 2020

Emerging companies have historically been backed by venture capital funds, but as Europe’s startup scene matures, involvement by more traditional private equity investors is growing, particularly in the tech, consumer, and...more

The Rise of Growth Equity - Connecting PE and VC

As private equity targets emerging companies, PE investors are expanding VC deal terms and dynamics. Emerging companies have historically been backed by venture capital funds, but as Europe’s startup scene matures,...more

Culture and Conduct Ahead of Exit - Key Points for Private Equity

Buyout firms planning an acquisition or preparing a portfolio company for exit must consider the impact of poor corporate culture, particularly on a potential IPO. No institution, whatever its geography, industry, sector,...more

Focus on Culture and Conduct Brings New Considerations for Corporates and Investors

It is now apparent that no institution or business unit, whatever its geography, industry, sector, or size, is above the negative impact of a poor culture. Culture-related issues at Uber, Sports Direct, Boeing, and others...more

UK Announces Full Details of Future Fund Scheme to Support Startups in COVID-19 Era

The scheme opens on 20 May 2020 and is available on a “first come, first served” basis. On 18 May 2020, the UK government released a draft of its convertible loan note agreement and details of the application process for...more

UK Announces New Funds to Support Startups in the COVID-19 Era

The UK government is pledging at least £250 million in convertible loan notes to UK-registered businesses. On 20 April 2020, the UK government issued a press release announcing a new Future Fund scheme for the financing of...more

Minimising and Mitigating Risk in M&A - Trusted Tools and New Solutions

In a complex and competitive market, minimising and mitigating risk in M&A is a key concern for deal teams. High demand for assets saw strong deal volumes and values in 2019, following a standout year in 2018. The search for...more

Corporate Reorganisations 2019

‘Corporate reorganisation’ is something of an umbrella term, and is used in many different contexts to mean a multitude of different things. At one extreme, a reorganisation may refer to ‘paper’ changes to a corporate group’s...more

Time to Prepare for New EU Medical Device Regime

Companies should act now to prepare for the full implementation of the MDR and IVDR. On 26 May 2020, Regulation (EU) 2017/745 on medical devices (MDR) will become fully active, reflecting an overhaul of the current...more

Making Your Carve-Out a Clean Cut

Corporates should leverage growing carve-out and divestment activity across the European market with a strategic approach to deal making. In the current deal market, corporates are taking an increasingly strategic and...more

MHRA Releases No-Deal Brexit Guidance for Life Sciences Companies

The guidance provides helpful clarity on key regulatory changes impacting life sciences companies in the event of a no-deal Brexit. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published a...more

WORD OF THE DAY® – 8+2+1 [Video]

Latham partner Robbie McLaren explains the term 8+2+1 from the Book of Jargon® – Healthcare & Life Sciences. The Book of Jargon® – Healthcare & Life Sciences is one of a series of practice area and industry-specific...more

11/17/2017

Pharma and Biotech: Key Trends and Legal Risks

How to thrive amid uncertainty? This was the question we explored at the 35th FT Global Pharmaceutical and Biotechnology Conference. Here are five key industry trends and corresponding practical legal tips to help companies...more

M&A Deal Terms in 2017: What Can Deal Teams Expect?

Britain’s decision to leave the European Union in June 2016, coupled with the election of Donald Trump as US president in November 2016, gave dealmakers plenty of pause for thought last year – but ultimately did little to...more

21 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide